Antisense Therapeutics Limited (ASX:ANP) shareholders will doubtless be very grateful to see the share price up 44% in the last week. But over the last half decade, the stock has not performed well.

Zero-debt allows substantial financial flexibility, especially for small-cap companies like Antisense Therapeutics Limited (ASX:ANP), as the company does not have to adhere to strict debt covenants.

Anyone researching Antisense Therapeutics Limited (ASX:ANP) might want to consider the historical volatility of the share price. Modern finance theory considers volatility to be a measure of risk, and ...

What is the current share price of Antisense Therapeutics Limited (ANP)? Antisense Therapeutics Limited's (ANP) current share price is $0.06. This constitutes a price movement of 1.69% when compared ...

Mark Diamond has been the CEO of Antisense Therapeutics Limited (ASX:ANP) since 2001. This analysis aims first to contrast CEO compensation with other companies that have similar market capitalization ...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining exploration companies often lose money for years before finding success with a new ...

Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable business and finance news content to a global investment audience. All our content is produced ...

Antisense Therapeutics Limited (ANP) options are a category of derivatives that give the holder the right, but not the obligation, to buy or sell the underlying security for a predefined exercise ...